| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| pa-799 | pi3-kinase alpha | NA | Successful target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.17 | phase 1/2 | inhibitor |
| pa-799 | pi3-kinase beta | NA | Clinical trial target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.16 | phase 1/2 | inhibitor |
| pa-799 | pi3-kinase delta | NA | Successful target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.17 | phase 1/2 | inhibitor |
| pa-799 | pi3-kinase gamma | NA | Successful target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.11 | phase 1/2 | inhibitor |
| pa-799 | pi3-kinase gamma | NA | Successful target | TTD , DGIDB | Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.11 | phase 1/2 | unknown |
| click here to return to the previous page | ||||||||